HAG:XETRHENSOLDT AG Analysis
Data as of 2026-05-25 - not real-time
$10.31
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Hensoldt AG is currently priced well above its intrinsic valuation, with market pricing that exceeds the discounted cash flow estimate and a price‑to‑earnings multiple that dwarfs the industry average. The stock shows a bullish technical backdrop – the moving averages sit below the current price, MACD is in a bullish configuration and momentum indicators remain comfortably below overbought levels – yet the overall trend is described as neutral. Revenue growth remains robust, but margins are thin and operating profitability is marginal, contributing to a valuation gap. The dividend yield is modest, though cash flow generation and a moderate payout ratio suggest sustainability. Increased trading activity points to rising interest, but high recent volatility and a beta near market levels amplify risk considerations.
Given the juxtaposition of strong top‑line growth against elevated valuation and sector‑specific uncertainties, the stock may appeal to investors seeking exposure to defense technology but warrants careful positioning. The combination of a high price relative to fair value, substantial volatility, and a balanced dividend profile underlines the need for a nuanced, time‑horizon‑specific approach.
Given the juxtaposition of strong top‑line growth against elevated valuation and sector‑specific uncertainties, the stock may appeal to investors seeking exposure to defense technology but warrants careful positioning. The combination of a high price relative to fair value, substantial volatility, and a balanced dividend profile underlines the need for a nuanced, time‑horizon‑specific approach.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- bullish technical signals but neutral overall trend
- price above intrinsic valuation
- high short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- sustained revenue growth outpacing peers
- potential for margin improvement
- moderate dividend sustainability
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- defense sector cyclicality and regulatory exposure
- valuation gap may persist without earnings acceleration
- steady cash flow supporting dividend
Key Metrics & Analysis
Financial Health
Revenue Growth25.60%
Profit Margin3.91%
P/E Ratio85.9
ROE10.30%
ROA2.92%
Debt/Equity167.14
P/B Ratio10.7
Op. Cash Flow$498.0M
Free Cash Flow$265.5M
Industry P/E29.7
Technical Analysis
TrendNeutral
RSI64.5
Support$8.16
Resistance$10.46
MA 20$9.04
MA 50$9.03
MA 200$9.80
MACDBullish
VolumeIncreasing
Fear & Greed Index91.75
Valuation
Fair Value$7.45
GradeOvervalued
TypeGrowth
Dividend Yield0.62%
Risk Assessment
Beta1.02
Volatility58.24%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.